Breath test study for IBD in remission with IBS symptoms
Part of Digestive system clinical trials.
This study tests a device called AIRE-2 that analyzes your breath to see if it can help manage IBD symptoms. It is for people with IBD who are in remission but still have IBS-like symptoms like belly pain or bloating.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 75 years old
- Have a diagnosis of ulcerative colitis or Crohn's disease
- Be in remission for at least 3 months
- Have at least one IBS-like symptom (such as abdominal pain, gas, or changes in bowel habits)
- Own a smartphone with Bluetooth
- Speak English fluently and be able to use smartphone apps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well the anal area works in people with inflammatory bowel disease (IBD), even when your bowel disease is “in remission” but you may still have symptoms. It may help doctors better understand the cause of ongoing problems and guide future care.
This trial studies whether a breath test (hydrogen/methane lactose testing) can predict who with IBS will improve on a lactose-free diet. If you have moderate-to-severe IBS and regularly eat lactose-containing foods, the test result may help tailor your diet approach.
This trial tests a personalized low-FODMAP diet plan, a diet that avoids certain carbohydrates that can trigger gut symptoms, using a mobile app to help manage IBS. It aims to see if this approach improves symptoms and how it affects the connection between your gut and your brain.
This study looks for signs in your body—like breath and blood tests—that can show how well you are following a special diet for IBS. It aims to find better ways to track diet compliance, which could help make dietary treatments more effective.
This study tests a new breath test to see if a digestive enzyme problem (sucrase-isomaltase deficiency) causes IBS symptoms. If you have IBS, this could help find a specific cause and lead to better treatment.
This study checks how sensitive your gut is to normal stimuli in people with IBS, ulcerative colitis, Crohn’s disease, and in healthy volunteers. Results may help researchers understand why some people feel more abdominal discomfort and how that connects to inflammatory bowel conditions.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.